Showing results (31-40 of 157) with videos related to
Sort By:
Pageof 16
Radiation Oncology Journal|October 8, 2021
Risk of second cancer among young prostate cancer survivorsHong Zhang, Andrew Yu, Andrea Baran, et al.Nature Reviews. Urology|May 2, 2018
Historical and contemporary perspectives on cribriform morphology in prostate cancerMatthew Truong, Thomas Frye, Edward Messing, et al.Cancer|July 2, 2011
Neoadjuvant gemcitabine and cisplatin chemotherapy for locally advanced urothelial cancer of the bladderEmil Scosyrev, Edward M Messing, Edwin van Wijngaarden, et al.Urology|April 13, 2010
Lost and now found: retained straight catheter for 20 yearsEmma Ester Bendaña, Deep Trivedi, Jonah Marshall, et al.Journal of Clinical Imaging Science|September 15, 2011
Bilateral testicular epidermoid cystsNorman Loberant, Shweta Bhatt, Edward Messing, et al.CPT: Pharmacometrics & Systems Pharmacology|August 23, 2025
Model-Informed Drug Development for Ligelizumab in Patients With Chronic Spontaneous UrticariaAndrzej Bienczak, Aurelie Gautier, Eva Hua, et al.JAMA Health Forum|August 17, 2022
International Country-Level Trends, Factors, and Disparities in Compassionate Use Access to Unlicensed Products for Patients With Serious Medical ConditionsPaul Aliu, Séverine Sarp, Ramona Reichenbach, et al.Advances in Therapy|January 24, 2022
A Review of the Unique Drug Development Strategy of Indacaterol Acetate/Glycopyrronium Bromide/Mometasone Furoate: A First-in-Class, Once-Daily, Single-Inhaler, Fixed-Dose Combination Treatment for AsthmaDominic Brittain, Peter D'Andrea, Emilie Gruen, et al.Expert Review of Cardiovascular Therapy|March 9, 2013
HDL-C: clinical equipoise and vascular endothelial functionSteven Campbell, Jacques GenestRespiratory Medicine|March 12, 2021
Cardiovascular safety of mometasone/indacaterol and mometasone/indacaterol/glycopyrronium once-daily fixed-dose combinations in asthma: pooled analysis of phase 3 trialsEmil Scosyrev, Richard van Zyl-Smit, Huib Kerstjens, et al.Pageof 16